Publications:51
- Home
- Profiles
Jing Liu, PhD
- About Me
- Publications
- Industry Relationships
About Me
Language
Position
About Me
Language
Position
Publications
Selected Publications
- Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor. Yan Xiong, Holger Greschik, Catrine Johansson, Ludwig Seifert, Vicki Gamble, Kwang Su Park, Vincent Fagan, Fengling Li, Irene Chau, Masoud Vedadi, Cheryl H. Arrowsmith, Paul Brennan, Oleg Fedorov, Manfred Jung, Gillian Farnie, Jing Liu, Udo Oppermann, Roland Schüle, Jian Jin. Journal of Medicinal Chemistry
- Structurally Specific Z-DNA Proteolysis Targeting Chimera Enables Targeted Degradation of Adenosine Deaminase Acting on RNA 1. Zhen Wang, Dingpeng Zhang, Xing Qiu, Hiroyuki Inuzuka, Yan Xiong, Jing Liu, Li Chen, He Chen, Ling Xie, H. Ümit Kaniskan, Xian Chen, Jian Jin, Wenyi Wei. Journal of the American Chemical Society
- USP7-Based Deubiquitinase-Targeting Chimeras Stabilize AMPK. Jing Liu, Xiaoping Hu, Kaixiu Luo, Yan Xiong, Li Chen, Zhen Wang, Hiroyuki Inuzuka, Chao Qian, Xufen Yu, Ling Xie, Adil Muneer, Dingpeng Zhang, Joao A. Paulo, Xian Chen, Jian Jin, Wenyi Wei. Journal of the American Chemical Society
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Liu has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.